Increased Risk of Aspiration Pneumonia Associated With Endoscopic Procedures Among Patients With Glucagon-like Peptide 1 Receptor Agonist Use

AGA rapid clinical practice update on the management of patients taking GLP-1 receptor agonists prior to endoscopy: communication.

Hashash, J. G., Thompson, C. C., & Wang, A. Y. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.11.002 · Cited by 140

ASA Consensus-based Guidance on Preoperative Management of Patients on Glucagon-like Peptide-1 Receptor Agonists

Ushakumari, D. S., & Sladen, R. N. (2024) · Anesthesiology · doi:10.1097/aln.0000000000004776 · Cited by 139

Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration

van Zuylen, M. L., Siegelaar, S. E., Plummer, M. P., Deane, A. M., Hermanides, J., & Hulst, A. H. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.01.001 · Cited by 132

Pulmonary scintigraphy for diagnosis of aspiration during intravenous propofol anaesthesia for colonoscopy †

Rézaiguia-Delclaux, S., Streich, B., Bouleau, D., Delchier, J. C., Dhonneur, G., Meignan, M. A., & Duvaldestin, P. (2001) · British Journal of Anaesthesia · doi:10.1093/bja/87.2.204 · Cited by 15

Pulmonary aspiration during procedural sedation for colonoscopy resulting from positional change managed without oral endotracheal intubation

Parker, J. D. (2020) · JA Clinical Reports · doi:10.1186/s40981-020-00360-5 · Cited by 12

Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity

Drucker, D. J. (2024) · Diabetes Care · doi:10.2337/dci24-0003 · Cited by 383

Mapping the effectiveness and risks of GLP-1 receptor agonists

Xie, Y., Choi, T., & Al-Aly, Z. (2025) · Nature Medicine · doi:10.1038/s41591-024-03412-w · Cited by 300

Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide

Jalleh, R. J., Plummer, M. P., Marathe, C. S., Umapathysivam, M. M., Quast, D. R., Rayner, C. K., Jones, K. L., Wu, T., Horowitz, M., & Nauck, M. A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae719 · Cited by 157

Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association

El‐Boghdadly, K., Dhesi, J., Fabb, P., Levy, N., Lobo, D. N., McKechnie, A., Mustafa, O., Newland‐Jones, P., Patel, A., Pournaras, D. J., et al. (2025) · Anaesthesia · doi:10.1111/anae.16541 · Cited by 147

Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions

Jalleh, R. J., Rayner, C. K., Hausken, T., Jones, K. L., Camilleri, M., & Horowitz, M. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00188-2 · Cited by 144

Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement

Oprea, A. D., Ostapenko, L. J., Sweitzer, B., Selzer, A., Irizarry-Alvarado, J. M., Hurtado Andrade, M. D., Mendez, C. E., Kelley, K. D., Stewart, E., Fernandez Robles, C. R., et al. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2025.04.001 · Cited by 104

Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study

Alkabbani, W., Suissa, K., Gu, K. D., Cromer, S. J., Paik, J. M., Bykov, K., Hobai, I., Thompson, C. C., Wexler, D. J., & Patorno, E. (2024) · BMJ · doi:10.1136/bmj-2024-080340 · Cited by 60

Postoperative Aspiration Pneumonia Among Adults Using GLP-1 Receptor Agonists

Chen, Y.-H., Zink, T., Chen, Y.-W., Nin, D. Z., Talmo, C. T., Hollenbeck, B. L., Grant, A. R., Niu, R., Chang, D. C., & Smith, E. L. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.0081 · Cited by 60

Association between glucagon-like peptide-1 receptor agonist use and peri-operative pulmonary aspiration: a systematic review and meta-analysis

Castrillon, J., Rele, S., Sumithran, P., Hii, M., Thuraisingam, S., Spelman, T., Phan, T., Choong, P., Dowsey, M., & Shadbolt, C. (2025) · Anaesthesia · doi:10.1111/anae.16601 · Cited by 65

Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Gastrointestinal Endoscopy: A Meta-Analysis

Facciorusso, A., Ramai, D., Dhar, J., Samanta, J., Chandan, S., Gkolfakis, P., Crinò, S. F., Maida, M., Anderloni, A., Boskoski, I., et al. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.07.021 · Cited by 59

Association of Perioperative Glucagon-like Peptide-1 Receptor Agonist Use and Postoperative Outcomes

Aschen, S. Z., Zhang, A., O’Connell, G. M., Salingaros, S., Andy, C., Rohde, C. H., & Spector, J. A. (2024) · Annals of Surgery · doi:10.1097/sla.0000000000006614 · Cited by 63

Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning

Kim, J. A., & Yoo, H. J. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0242 · Cited by 71

Glucagon-Like Peptide-1 Receptor Agonists Do Not Increase Aspiration During Upper Endoscopy in Patients With Diabetes

Barlowe, T. S., Anderson, C., Sandler, R. S., Subramaniam, D., Muratore, A., Buse, J. B., Gouker, L. N., Majithia, R. T., Shaheen, N. J., Stürmer, T., et al. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.04.038 · Cited by 55

Glucagon-like peptide-1 receptor agonist use and the risk of residual gastric contents and aspiration in patients undergoing GI endoscopy: a systematic review and a meta-analysis.

Baig, M. U., Piazza, A., Lahooti, A., Johnson, K. E., Rangwani, S., Gouda, Z., Mahadev, S., Newberry, C., Hanscom, M., Sampath, K., et al. (2025) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2024.12.019 · Cited by 54

Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025

Panganiban, J. A., Kehar, M., Ibrahim, S. H., Hartmann, P., Sood, S., Hassan, S. M., Ramirez, C. M., Kohli, R., Censani, M., Mauney, E. E., et al. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100164 · Cited by 55

2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists

HOCKING, S. L., Scott, D. A., Remedios, M. L., Horowitz, M., Story, D., Greenfield, J. R., Boussioutas, A., Devereaux, B., Andrikopoulos, S., Shaw, J. E., et al. (2025) · Anaesthesia and Intensive Care · doi:10.1177/0310057x251355288 · Cited by 57

Perioperative Management of Patients Taking Glucagon-like Peptide-1 Receptor Agonists: Applying Evidence to Clinical Practice

Oprea, A. D., Umpierrez, G. E., Sweitzer, B., & Hepner, D. L. (2024) · Anesthesiology · doi:10.1097/aln.0000000000005204 · Cited by 42

Food Retention at Endoscopy Among Adults Using Glucagon-Like Peptide-1 Receptor Agonists

Nasser, J., Hosseini, A., Barlow, G. M., Gianchandani, R. Y., Rezaie, A. R., Pimentel, M., & Mathur, R. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.36783 · Cited by 33

Evaluation of safety of preoperative GLP-1 receptor agonists in patients undergoing elective surgery: a systematic review, meta-analysis and meta-regression

Kamarajah, S. K., Gudiozzi, N., Findlay, J. M., Lee, M. J., Pinkney, T., & Markar, S. R. (2025) · eClinicalMedicine · doi:10.1016/j.eclinm.2025.103408 · Cited by 29

The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications

Jalleh, R. J., Talley, N. J., Horowitz, M., & Nauck, M. A. (2026) · Journal of Clinical Investigation · doi:10.1172/jci194740 · Cited by 40

Comparative estimate of glucose-lowering therapies on risk of incident pneumonia and severe sepsis: an analysis of real-world cohort data

Henney, A. E., Riley, D. R. J., Hydes, T., Anson, M., Ibarburu, G. H., Frost, F., Alam, U., & Cuthbertson, D. J. (2024) · Thorax · doi:10.1136/thorax-2024-221906 · Cited by 35

Gastrointestinal Motility Effects of GLP-1 Receptor Agonists

Bellavance, D. R., Chua, S. G., & Mashimo, H. L. (2025) · Current Gastroenterology Reports · doi:10.1007/s11894-025-00995-3 · Cited by 27

GLP-1 Agonists for Weight Loss: Do They Increase Complications in Non-diabetic Patients Undergoing Primary Total Hip Arthroplasty?

Verhey, J. T., Austin, R. P., Tarabichi, S., Paul, B., Deckey, D. G., Christopher, Z. K., Spangehl, M. J., & Bingham, J. S. (2025) · The Journal of Arthroplasty · doi:10.1016/j.arth.2025.03.012 · Cited by 25

Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy

Nicze, M., Dec, A., Borówka, M., Krzyżak, D., Bołdys, A., Bułdak, Ł., & Okopień, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158202 · Cited by 30

American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors

Sharaiha, R. Z., Shukla, A. P., Sen, S., Chan, W. W., Broome, D. T., Anca, D., Abidi, W. M., Marya, N. B., Muniraj, T., Thosani, N. C., et al. (2025) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2024.10.057 · Cited by 23

Perioperative management of patients on GLP-1 receptor agonists: Risks, recommendations, and future directions—A narrative review

Li, X., Jin, Y., Feng, X.-Y., Wang, R.-C., Chen, J.-P., & Lu, B. (2025) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2025.111871 · Cited by 22

Impact of GLP-1 receptor agonists on upper gastrointestinal endoscopy: an updated systematic review and meta-analysis

Abdulraheem, A., Abujaber, B. A., Ayers, L., Zureikat, Q. A., Bashiri, K., Almhanni, G., Altork, N. A., Afzal, U., Qarkash, D., Spyros, P., et al. (2025) · Surgical Endoscopy · doi:10.1007/s00464-025-11962-4 · Cited by 19

Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons

Cedirian, S., Donati, M., Rapparini, L., Pampaloni, F., Plaça, M. L., Sgarzani, R., Negosanti, L., Raschi, E., & Starace, M. V. R. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01537-5 · Cited by 25

Impact of Preoperative Glucagon‐Like Peptide‐1 Receptor Agonist on Outcomes Following Major Surgery

Rashid, Z., Woldesenbet, S., Khalil, M., Altaf, A., Kawashima, J., Mumtaz, K., & Pawlik, T. M. (2025) · World Journal of Surgery · doi:10.1002/wjs.12484 · Cited by 19

Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms

Goldenberg, R., Gilbert, J. D., Houlden, R. L., Khan, T., Makhija, S., Mazer, C. D., Trinacty, J., & Verma, S. (2025) · Current Medical Research and Opinion · doi:10.1080/03007995.2025.2458538 · Cited by 20

Glucagon-like peptide-1 receptor agonists and capsule endoscopy in patients with diabetes: a matched cohort study

Odah, T., Vattikonda, A., Stark, M. E., Brahmbhatt, B. S., Lukens, F., Badurdeen, D., Hashash, J. G., & Farraye, F. A. (2024) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2024.07.014 · Cited by 18

No association between semaglutide and postoperative pneumonia in people with diabetes undergoing elective surgery

Welk, B., McClure, J. A., Carter, B., Clarke, C., Dubois, L., & Clemens, K. K. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15711 · Cited by 16

Association of glucagon-like peptide-1 receptor agonist use with risk of infections: A systematic review and meta-analysis

Han, S., Liu, Y., Xing, B., Yang, Y., Liu, Z., Li, Y., Wang, X., Yu, J., Ping, F., Li, W., et al. (2025) · Journal of Infection · doi:10.1016/j.jinf.2025.106645 · Cited by 16

Association between Glucagon-like Peptide-1 Receptor Agonists and Aspiration Pneumonia during Endoscopic Procedures

Peng, C.-Y., Chang, Y.-C., Gong, C., Chang, Y., Chi, K., Hsiao, C.-L., Chiang, C., & Chiang, C. (2024) · Anesthesiology · doi:10.1097/aln.0000000000005174 · Cited by 16

Glucagon-Like Peptide-1 Receptor Agonists and Peri-Procedural Aspiration Risk

Ho, C., Ayers, A. T., Kohn, M. A., Umpierrez, G. E., & Klonoff, D. C. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf088 · Cited by 15

Evidence Report on the Safety of Gastrointestinal Endoscopy in Patients on Glucagon-like Peptide-1 Receptor Agonists: A Systematic Review and Meta-Analysis

Tarar, Z. I., Farooq, U., Chaudhry, A., Gandhi, M. H., Alayli, A. E., Ayoub, M., Singh, B., Daglilar, E. S., & Thosani, N. C. (2025) · Diagnostics · doi:10.3390/diagnostics15060770 · Cited by 15

Endoscopy and anesthesia outcomes associated with glucagon-like peptide-1 receptor agonist use in patients undergoing outpatient upper endoscopy

Panchal, S., Mahmud, N., Atkins, J. H., Kang, H., Leto, A. C., Goebel, A. M., Trivedi, N., Chatila, A. T., Hsu, W.-W., Ginsberg, G. G., et al. (2025) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2025.01.004 · Cited by 14

Glucagon-like peptide-1 receptor agonists increase the risk of residual gastric content and pulmonary aspiration on upper endoscopy: A meta-analysis

Tan, Y. C. R. S., Zhang, X., Lv, X., Sun, Y.-N., Yang, J., & Xiao, X. (2025) · Digestive and Liver Disease · doi:10.1016/j.dld.2025.03.002 · Cited by 12

Perioperative Management of GLP-1 Receptor Agonists: Balancing Aspiration Risk with Therapeutic Benefit

Lim, E. C. N., & Lim, C. E. D. (2025) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-025-02079-9 · Cited by 12

Preoperative GLP-1 agonist use is not associated with perioperative aspiration or pneumonia: an observational study using US national data

Poeran, J., Iban, Y. C., Zhong, H., Illescas, A., Cozowicz, C., Reisinger, L., Liu, J., & Memtsoudis, S. G. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2025.01.038 · Cited by 11

A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia

Vetrugno, L., Deana, C., Porto, A. D., Boero, E., Bellini, V., Biasucci, D. G., & Bignami, E. G. (2025) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-025-00237-y · Cited by 12

Glucagon-like-peptide-1 (GLP-1) receptor agonist use and the risk of pulmonary aspiration in patients undergoing surgery

Wright, J. D., Chen, L., Xu, X., Hur, C., Matsuo, K., Elkin, E. B., & Hershman, D. L. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002425 · Cited by 14

GLP-1 Agonists and the Risk of Pulmonary Aspiration during Elective Upper Endoscopy: A Systematic Review and Meta-analysis

Elmati, P. R., Jagirdhar, G. S. K., Qasba, R. K., Perez, A., Qasba, R. K., Bains, Y., Shah, M., & Surani, S. (2025) · The Open Respiratory Medicine Journal · doi:10.2174/0118743064372550250603061720 · Cited by 11

GLP-1 Receptor Agonists and Gastrointestinal Endoscopy: A Narrative Review of Risks, Management Strategies, and the Need for Clinical Consensus

Crespo, J., Rodríguez-Duque, J. C., Iruzubieta, P., Cerda, E. C. M., & Velasco, J. A. V.-R. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155597 · Cited by 8

Definite benefits of GLP-1 receptor agonists: what is the risk of gastroparesis and lung aspiration?

Camilleri, M. (2024) · Gut · doi:10.1136/gutjnl-2024-333036 · Cited by 8

Comparing the risk of gastroparesis following different modalities for treating obesity: semaglutide versus bupropion-naltrexone versus sleeve gastrectomy – a retrospective cohort study

Aneke-Nash, C. S., Hung, K. S., Wall‐Wieler, E., Zheng, F., & Sharaiha, R. Z. (2025) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2024-001704 · Cited by 9

Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on Retained Gastric Contents During Esophagogastroduodenoscopy: A Propensity Score‐Matched Study

Hisada, H., Tsuji, Y., Kubota, D., Miura, Y., Mizutani, H., Ohki, D., Yakabi, S., Takeuchi, C., Kakushima, N., Yamamichi, N., et al. (2025) · Digestive Endoscopy · doi:10.1111/den.70016 · Cited by 6

Glucagon-like peptide-1 Agonists and Common Hand Procedures: Perioperative and Postoperative Risks and Complications

Amen, T. B., Ibrahim, L. I., Gillinov, S. M., Torabian, K. A., Dean, M. C., Liimakka, A. P., & Lee, S. K. (2025) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2025.08.004 · Cited by 7

Impact of gastric emptying and small intestinal carbohydrate absorption on glycemia in health and diabetes: therapeutic implications

Jalleh, R. J., Wu, T., Umapathysivam, M. M., Young, R. L., Jones, K. L., Marathe, C. S., Rayner, C. K., Plummer, M. P., & Horowitz, M. (2026) · Physiological Reviews · doi:10.1152/physrev.00009.2025 · Cited by 6

GLP-1 receptor agonist use does not increase risk of respiratory complications post-endoscopy

Velji-Ibrahim, J., Nathani, P., Patel, H. K., & Sharma, P. (2025) · Endoscopy International Open · doi:10.1055/a-2487-2937 · Cited by 6

Sedation for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) Guideline

Τriantafyllou, Κ., Tziatzios, G., Tham, T., Beilenhoff, U., Lorenzo‐Zúñiga, V., Pouw, R. E., Roelandt, P. R., van Malenstein, H., Vilmann, P., Voiosu, T., et al. (2026) · Endoscopy · doi:10.1055/a-2898-6540 · Cited by 6

Rates of repeat EGD in nondiabetic adults with glucagon-like peptide-1 receptor agonist prescription: a retrospective matched cohort study

Elangovan, A., Aggarwal, P., Kaelber, D. C., & Shah, R. (2024) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2024.10.004 · Cited by 5

Coming full circle: could glucagon-like peptide-1 receptor agonists confer a net perioperative benefit?

Hobai, I. A., Baerdemaeker, L. D., & Dhatariya, K. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2025.10.003 · Cited by 4

Peri-Procedural Safety of GLP-1 Receptor Agonists in Elective Endoscopy: A Multicenter Retrospective Cohort Study

Kalsi, H., Bassi, R., Noureldine, H. A., Essilfie‐Quaye, K., Creamer, C. C., Abuassi, M. A., Meadows, R., Brar, T. S., & Perbtani, Y. B. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14176147 · Cited by 4

Liver, Cardiovascular and Infectious Outcomes in Alcohol‐Associated Liver Disease With Cardiometabolic Risk Factors

Danpanichkul, P., Duangsonk, K., Pang, Y.-F., Rakwong, K., Jit-Are-Roon, P., Wattanachayakul, P., Srikulmontri, T., Nah, B., Chen, V. L., Kim, D., et al. (2026) · Liver international (Print) · doi:10.1111/liv.70575 · Cited by 1

Practical management of glucagon-like peptide-1 receptor agonists in gastroenterology: a position paper by the Italian Society of Gastroenterology (SIGE)

Facciorusso, A., Giannini, E. G., Tacelli, M., Zanetto, A., Spada, C., Boskoski, I., Furnari, M., Pennisi, G., Capurso, G., Vitello, A., et al. (2026) · Digestive and Liver Disease · doi:10.1016/j.dld.2026.02.018 · Cited by 3

Measuring the Quality and Safety of Upper Endoscopy in Patients Taking Glucagon-like Peptide 1 Receptor Agonists

Bansal, R., Khan, R., & Grover, S. C. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.04.001 · Cited by 3

Do Glucagon-like Peptide 1 Receptor Agonists Cause Postendoscopic Aspiration Pneumonia?

Hartmann, P. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.04.002 · Cited by 3

Glucagon-like Peptide 1 Receptor Agonists and Postendoscopic Aspiration Pneumonia: What Plays a Role in Clinical Practice?

Xu, H., & Lin, L. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.04.007 · Cited by 3

Treatment with Antihistamines and the Risk of Liver Cancer in Patients with Viral Hepatitis: A Multi-Center Cohort Study

Chan, S., Chang, Y., Polpichai, N., Lee, Y., & Sheng‐Kai, K. (2024) · Viruses · doi:10.3390/v16060940 · Cited by 3

Glucagon-like Peptide 1 Receptor Agonists and Risk of Adverse Anesthesia Events: Caution Warranted When Interpreting Associations With Pulmonary Aspiration

Zandvakili, I., Hsu, W.-W., & Ginsberg, G. G. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.06.040 · Cited by 3

Pulmonary aspiration during upper endoscopy in a patient prescribed semaglutide

Dong, T., Wang, L., Wang, H., & Xiao, J. F. (2024) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2024.10844/2024 · Cited by 3

The 2024 top 10 list of endoscopy topics in medical publishing: an annual review by the American Society for Gastrointestinal Endoscopy Editorial Board

Martínez, M., Bartel, M. J., Chua, T. Y., Dakhoul, L., Fatima, H., Glessing, B. R., Jensen, D., Lara, L. F., Shinn, B., Tadros, M. S., et al. (2025) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2025.04.004 · Cited by 3

Adverse effects and other aspects of drugs with incretin effect

Ballesteros-Pomar, M. D., & Lesmes, I. B. (2025) · Medicina Clínica (English Edition) · doi:10.1016/j.medcli.2025.107041 · Cited by 3

Glucagon‐like peptide‐1 receptor agonist and respiratory complications after endoscopy: A Japanese nationwide cohort study

Hisada, H., Ikeuchi, K., Tsuji, Y., Yamamichi, N., Kakushima, N., Okushin, K., Yakabi, S., Takeuchi, C., Ohki, D., Mizutani, H., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70194 · Cited by 2

Perioperative management of patients taking glucagon-like peptide-1 receptor agonists: a restrictive fasting regimen is not necessary. Comment on Br J Anaesth 2025; 135: 48–78

Khandaker, R., Jahantighi, A. B., Schwarz, J. N., Himes, C. P., Isono, S., Eikermann, M., & Fassbender, P. J. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2025.09.027 · Cited by 2

Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like Peptide-1 Receptor Agonists

Joshi, G. P. (2025) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000007921 · Cited by 2

Gastric Motility Assays May Not Capture the Entire Clinical Picture in Patients Using Glucagon-Like Peptide-1 Receptor Agonists

Hobai, I. A. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002949 · Cited by 2

Aspiration risk and strategic approach for patients receiving GLP-1 receptor agonists undergoing elective surgery

Li, J., Mohamed, B. A., Huang, S., & Peng, Y. G. (2025) · Current Medical Research and Opinion · doi:10.1080/03007995.2025.2494646 · Cited by 3

Managing noninsulin glucose-lowering medications before surgery: A comparison of clinical practice guidelines

Morey‐Vargas, O. L., Gossmann, M., Ketz, J. M., & Abdelmalak, B. (2025) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.92a.24118 · Cited by 4

With Great Statistical Power Comes Great Responsibility: Pitfalls of Claims Database Research on the Periprocedural Glucagon-like Peptide 1 Receptor Agonist Management Debate

Hiramoto, B. A., McCarty, T. R., Muftah, M., & Chan, W. W. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.05.039 · Cited by 2

Delayed gastric emptying induced by glucagon-like peptide-1 receptor agonists and its implications for perioperative risk during anesthesia

Kang, D., & Choi, D. (2026) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2025.277 · Cited by 1

Navigating the clinical benefits, risks, and emerging controversies with glucagon-like peptide-1 receptor agonists

Sen, S., Pai, S., & Harbell, M. W. (2025) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000001522 · Cited by 1

Impact of GLP-1 receptor agonists on gastric residuals in patients receiving gastrointestinal endoscopic procedures

Le, K., Prasad, S., & Shah, R. (2025) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2025.2583025 · Cited by 1

Effect of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility during upper endoscopy in Asian patients with diabetes

Oh, Y. E., Kim, T., Ah, S., Park, H. J., Min, Y. W., Lee, H., Lee, J. H., Rhee, P., Kim, J. J., & Min, B. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i12.112694 · Cited by 2

Glucagon-like peptide-1 agonists and total shoulder arthroplasty outcomes: using natural language processing to assess postoperative risks and complications

Amen, T. B., Liimakka, A. P., Rudisill, S. S., Dean, M. W., Torabian, K. A., & Dyer, G. (2026) · Seminars in Arthroplasty JSES · doi:10.1016/j.sart.2026.151556 · Cited by 1

Pharmacotherapy for obesity management—Emphasizing the role of GLP-1 receptor agonist-based therapeutics

Warden, B. A., Duell, P. B., Bucheit, J. D., & Purnell, J. Q. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.11.013 · Cited by 1

Are patient factors associated with adverse perioperative outcomes in GLP-1 receptor agonist users? A retrospective cohort study

Fanizza, J. D., Moghaddam, A. S., & Atrash, A. (2026) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2026.112192 · Cited by 2

Glucagon-like peptide-1 drugs, gastrointestinal function and critical illness

Nadkarni, A., Deane, A. M., & Plummer, M. P. (2026) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001376 · Cited by 1

GLP-1 Receptor Agonists in Ear, Nose and Throat: A Review of Clinical Implications, Side Effects and High-Risk Airway Surgery Considerations

Somasundaram, S., Nightingale, J., Sreedharan, S., & Frauenfelder, C. (2026) · Ear Nose & Throat Journal · doi:10.1177/01455613261445013 · Cited by 1

Preoperative management algorithm for endoscopic or surgical interventions in patients receiving incretin mimetics

Салухов, В. В., Щеголев, А. В., Kryukov, E. V., Surzhikov, P. V., Apostolidi, E. V., & Prochik, Y. E. (2026) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2026-161 · Cited by 1

GLP-1 receptor agonist use and aspiration pneumonia risk following endovascular thrombectomy

Sardana, S., Mateti, N. R., Hackett, C., Singh, R., Bagga, S., Kotekal, D., Prahalad, A., Shakeel, H. A., Kamboj, N., Saim, M., et al. (2026) · Journal of NeuroInterventional Surgery · doi:10.1136/jnis-2026-025486 · Cited by 1

Perioperative Desaturation and Postoperative Nausea or Vomiting Requiring Antiemetic Administration in Glucagon‐Like Peptide‐1 Receptor Agonist Users Undergoing Ambulatory Ophthalmic Surgery Under Mild‐To‐Moderate Sedation: A Large Retrospective Cohort Study

Hyung, B., Ye, X. Y., Chandrakumar, M., Lovshin, J. A., & Peacock, S. C. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70955 · Cited by 1

Current Evidence and Practical Considerations for GLP-1 Receptor Agonists in Gynecologic Oncology

Neveu, J., Mateo-Kubach, P., Pervan, M., Meschini, T., Sabini, C., Martínez, Z. R. M., Loverro, M., Maureen, B., Villagrá, I., Del, M., et al. (2026) · International Journal of Gynecological Cancer · doi:10.1016/j.ijgc.2026.105660 · Cited by 1

Recent advances in perioperative care of patients using new antihyperglycaemic drugs and devices dedicated to diabetes

Ojaimi, R. E., Cheisson, G., Cosson, E., Ichaï, C., Jacqueminet, S., Catargi, B., Ouattara, A., Tauveron, I., Valensi, P. E., & Benhamou, D. (2024) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2024.101468 · Cited by 1

Controversies on the effects of GLP-1 receptor agonist treatment on gastric emptying

Rubio, M. Á., & Lesmes, I. B. (2025) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2025.101538 · Cited by 1

Glucagon-like Peptide-1 Receptor Agonists Are Not Associated With Increased Incidence of Pneumonia After Endoscopic Procedures

Tejada, N., Mansi, I. A., & de Melo, S. W. (2025) · Techniques and Innovations in Gastrointestinal Endoscopy · doi:10.1016/j.tige.2025.250925 · Cited by 1

Glucagon‐Like Peptide‐1 Receptor Agonists and Anesthesia—Are We Clearer on the Correct Approach?

Bloomgarden, Z. T. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.70041 · Cited by 2

Variability in the management of GLP-1 agonists and endoscopic procedures: an opportunity for standardization

Crespo, J., Arias, M. J. L., & Iruzubieta, P. (2025) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2025.11011/2024 · Cited by 1

Reply

Rezaie, A., & Yeo, Y. H. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.09.002

Response to Hobai

Hiramoto, B. A., McCarty, T. R., Muftah, M., & Chan, W. W. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003079

Getting to the Real Skinny on GLP-1RAs and the Risk of Aspiration During Endoscopy

Christie, J. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.08.035

GLP-1 receptor agonists and bronchial aspiration risk: what the evidence tells us

Fuccio, L., Arvanitakis, M., & Facciorusso, A. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00278-4

Controversias de los efectos del tratamiento con agonistas del receptor de GLP-1 sobre el vaciamiento gástrico

Rubio, M. Á., & Lesmes, I. B. (2024) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2024.12.001

Manejo preoperatorio de pacientes en tratamiento con análogos GLP-1: ¿suspender o individualizar?

Crespo, J., & Iruzubieta, P. (2025) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2024.11.010

Respuesta a Crespo et al., «Manejo preoperatorio de pacientes en tratamiento con análogos GLP-1: ¿suspender o individualizar?»

Velasco, J. A. V.-R., Barrientos-Ávalos, J. R., & Morel-Cerda, E. C. (2025) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2024.12.002

Response to Crespo et al., regarding ‘Preoperative management of patients receiving treatment with GLP-1 analogues: Withhold or individualize?’

Velasco, J. A. V.-R., Barrientos-Ávalos, J. R., & Morel-Cerda, E. C. (2025) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2024.12.004

Preoperative management of patients receiving treatment with GLP-1 analogues: Withhold or individualize?

Crespo, J., & Iruzubieta, P. (2025) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2024.11.007

GLP-1 Receptor Agonists and Endoscopic Procedural Optimization: How To Minimize Risk and Improve Outcomes

Barlowe, T. S., Gouker, L. N., Buse, J. B., Sandler, R. S., & Dougherty, M. (2025) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-025-00472-w

Glucagon-Like Peptide-1 (GLP-1a) Receptor Agonist Use in Patients Presenting for Gastroenterology Procedures

Wunder, L., Lee, R., & Welliver, D. (2025) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000891

Do Glucagon-like Peptide 1 Receptor Agonists Cause Postendoscopic Aspiration Pneumonia?

Hartmann, P. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.04.002 · Cited by 3

Measuring the Quality and Safety of Upper Endoscopy in Patients Taking Glucagon-like Peptide 1 Receptor Agonists

Bansal, R., Khan, R., & Grover, S. C. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.04.001 · Cited by 3

Glucagon-like Peptide-1 Receptor Agonists Are Not Associated With Increased Incidence of Pneumonia After Endoscopic Procedures

Tejada, N., Mansi, I. A., & de Melo, S. W. (2025) · Techniques and Innovations in Gastrointestinal Endoscopy · doi:10.1016/j.tige.2025.250925 · Cited by 1

Does the use of GLP-1 receptor agonists increase the risk of aspiration pneumonia in patients undergoing gastrointestinal endoscopy compared with non-users?

Tripdatabase (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.22132368

Do GLP-1 receptor agonists increase the risk of aspiration pneumonia in patients undergoing upper gastrointestinal endoscopy?

Tripdatabase (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.22124699